Stada Group
Kristina Aleksić has a diverse work experience spanning multiple roles and companies. Kristina currently works at STADA Group as a Technology Transfer Manager Team Lead since March 2022. Prior to that, they held the role of Technology Transfer Manager at the same company from January 2020 to March 2022. Before joining STADA Group, Kristina worked at Hemofarm A.D. where they served as a Senior Expert Associate in various departments such as Product Transfer, Analytical Development, and Pharmaceutical Development. Kristina started their career as an Internship Trainee at a Community Pharmacy from October 2014 to July 2015.
Kristina Aleksić obtained their Master's degree in Pharmacy from the University of Belgrade - Faculty of Pharmacy in the years 2009 to 2014. Kristina then pursued their PhD in Pharmaceutical Technology as a student at the same university starting from 2014.
Previous companies
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.